Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages

Journal of Experimental Medicine

Volumn 200, Issue 5, 2004, Pages 581-586

  Gold, Elizabeth S ^a   Simmons, Randi M ^a   Petersen, Timothy W ^a   Campbell, Lee Ann ^b   Kuo, Cho Chou ^b   Aderem, Alan ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bacterial infection; Innate immunity; Nitric oxide; Pathogen; Phagocytosis

Indexed keywords

AMPHIPHYSIN; NITRIC OXIDE;

ARTICLE; BACTERIAL SURVIVAL; CELL MATURATION; CELL SURVIVAL; CELL VACUOLE; CHLAMYDOPHILA PNEUMONIAE; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; BONE MARROW CELLS; CELL SEPARATION; CELL SURVIVAL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; GENETIC VECTORS; MACROPHAGES; MICE; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRITES; PHAGOCYTOSIS; PHAGOSOMES; TIME FACTORS; TRANSFECTION;

EID: 4544386813     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20040546     Document Type: Article

References (33)

1. Kuo, C.C., L.A. Jackson, L.A. Campbell, and J.T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
2. Thom, D.H., J.T. Grayston, D.S. Siscovick, S.P. Wang, N.S. Weiss, and J.R. Daling. 1992. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 268:68-72.
3. Muhlestein, J.B., E.H. Hammond, J.F. Carlquist, E. Radicke, M.J. Thomson, L.A. Karagounis, M.L. Woods, and J.L. Anderson. 1996. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J. Am. Coll. Cardiol. 27:1555-1561.
4. Muhlestein, J.B., J.L. Anderson, E.H. Hammond, L. Zhao, S. Trehan, E.P. Schwobe, and J.F. Carlquist. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 97:633-636.
5. von, H.L. 2002. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur. Respir. J. 19:546-556.
6. Gencay, M., J.J. Rudiger, M. Tamm, M. Soler, A.P. Perruchoud, and M. Roth. 2001. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am. J. Respir. Crit. Care Med. 163:1097-1100.
7. Villareal, C., J.A. Whittum-Hudson, and A.P. Hudson. 2002. Persistent Chlamydiae and chronic arthritis. Arthritis Res. 4:5-9.
8. Hannu, T., M. Puolakkainen, and M. Leirisalo-Repo. 1999. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford). 38:411-414.
9. Balin, B.J., H.C. Gerard, E.J. Arking, D.M. Appelt, P.J. Branigan, J.T. Abrams, J.A. Whittum-Hudson, and A.P. Hudson. 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. (Berl.). 187:23-42.
10. Sinai, A.P., and K.A. Joiner. 1997. Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu. Rev. Microbiol. 51:415-462.
11. Gold, E.S., N.S. Morrissette, D.M. Underhill, J. Guo, M. Bassetti, and A. Aderem. 2000. Amphiphysin 11m, a novel amphiphysin II isoform, is required for macrophage phagocytosis. Immunity. 12:285-292.
12. Gold, E.S., D.M. Underhill, N.S. Morrissette, J. Guo, M.A. McNiven, and A. Aderem. 1999. Dynamin 2 is required for phagocytosis in macrophages. J. Exp. Med. 190:1-8.
13. Morrissette, N.S., E.S. Gold, J. Guo, J.A. Hamerman, A. Ozinsky, V. Bedian, and A.A. Aderem. 1999. Isolation and characterization of monoclonal antibodies directed against novel components of macrophage phagosomes. J. Cell Sci. 112:4705-4713.
14. Kuo, C.C., and J.T. Grayston. 1990. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 162:755-758.
15. Kuo, C.C., H.H. Chen, S.P. Wang, and J.T. Grayston. 1986. Identification of a new group of Chlamydia psittaci strains called TWAR. J. Clin. Microbiol. 24:1034-1037.
16. Godzik, K.L., E.R. O'Brien, S.K. Wang, and C.C. Kuo. 1995. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. Clin. Microbiol. 33:2411-2414.
17. Underhill, D.M., A. Ozinsky, A.M. Hajjar, A. Stevens, C.B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 401:811-815.
18. Cox, D., C.C. Tseng, G. Bjekic, and S. Greenberg. 1999. A requirement for phosphatidylinositol 3-kinase in pseudopod extension. J. Biol. Chem. 274:1240-1247.
19. David, C., P.S. McPherson, O. Mundigl, and P. de Camilli. 1996. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. Proc. Natl. Acad. Sci. USA. 93:331-335.
20. McMahon, H.T., P. Wigge, and C. Smith. 1997. Clathrin interacts specifically with amphiphysin and is displaced by dynamin. FEBS Lett. 413:319-322.
21. Schmid, S.L., M.A. McNiven, and P. DeCamilli. 1998. Dynamin and its partners: a progress report. Curr. Opin. Cell Biol. 10:504-512.
22. Sarret, P., M.J. Esdaile, P.S. McPherson, A. Schonbrunn, H.J. Kreienkamp, and A. Beaudet. 2003. Role of amphiphysin 11 in somatostatin receptor trafficking in neuroendocrine cells. J. Biol. Chem. 279:8029-8037.
23. Mathew, D., A. Popescu, and V. Budnik. 2003. Drosophila amphiphysin functions during synaptic Fasciclin 11 membrane cycling. J. Neurosci. 23:10710-10716.
24. Leprince, C., E. Le Scolan, B. Meunier, V. Fraisier, N. Brandon, J. De Gunzburg, and J. Camonis. 2003. Sorting nexin 4 and amphiphysin 2, a new partnership between endocytosis and intracellular trafficking. J. Cell Sci. 116:1937-1948.
25. Peter, B.J., H.M. Kent, I.G. Mills, Y. Vallis, P.J. Butler, P.R. Evans, and H.T. McMahon. 2004. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science. 303:495-499.
26. Lee, E., M. Marcucci, L. Daniell, M. Pypaert, O.A. Weisz, G.C. Ochoa, K. Farsad, M.R. Wenk, and P. De Camilli. 2002. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science. 297:1193-1196.
27. Di, A., D.J. Nelson, V. Bindokas, M.E. Brown, F. Libunao, and H.C. Palfrey. 2003. Dynamin regulates focal exocytosis in phagocytosing macrophages. Mol. Biol. Cell. 14:2016-2028.
28. Rameh, L.E., and L.C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:8347-8350.
29. Coutinho-Silva, R., L. Stahl, M.N. Raymond, T. Jungas, P. Verbeke, G. Burnstock, T. Darville, and D.M. Ojcius. 2003. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity. 19:403-412.
30. Lee, C., S.R. Kim, J.K. Chung, M.A. Frohman, M.W. Kilimann, and S.G. Rhee. 2000. Inhibition of phospholipase D by amphiphysins. J. Biol. Chem. 275:18751-18758.
31. Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100:2417-2423.
32. Rottenberg, M.E., A.C. Gigliotti Rothfuchs, D. Gigliotti, C. Svanholm, L. Bandholtz, and H. Wigzell. 1999. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J. Immunol. 162:2829-2836.
33. Chesebro, B.B., E. Blessing, C.C. Kuo, M.E. Rosenfeld, M. Puolakkainen, and L.A. Campbell. 2003. Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis. Cardiovasc. Res. 60:170-174.